Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $48.3600 (1.07%) ($48.3600 - $48.3600) on Tue. Nov. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 77 | Latest Price | $48.3600(1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 3.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(32%) IWO(32%) IWM(31%) SDY(31%) | Factors Impacting HALO price | HALO will decline at least -1.025% in a week (0% probabilities). VIXM(-10%) VXX(-6%) TBT(-3%) XME(-2%) XBI(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $47.67(1.45%) | 10 Day Moving Average | $46.66(3.64%) | 20 Day Moving Average | $44.91(7.68%) | To recent high | -0.2% | To recent low | 25.6% | Market Cap | $6.609b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |